FAM1712A is a neuronal membrane receptor identified as a critical therapeutic target for Parkinson's disease (PD) . It acts as a neuronal receptor that selectively binds pathological α-synuclein, facilitating its neuron-to-neuron transmission—a key process in PD progression . Inhibiting FAM171A2 effectively blocks this propagation, offering a promising strategy to slow disease advancement